Please use this identifier to cite or link to this item: http://hdl.handle.net/10668/4400
Title: Dysfunction in the Cystic Fibrosis Transmembrane Regulator in Chronic Obstructive Pulmonary Disease as a Potential Target for Personalised Medicine
Authors: Carrasco-Hernández, Laura
Quintana-Gallego, Esther
Calero, Carmen
Reinoso-Arija, Rocío
Ruiz-Duque, Borja
López-Campos, José Luis
metadata.dc.contributor.authoraffiliation: [Carrasco-Hernández,L; Quintana-Gallego,E; Calero,C; Reinoso-Arija,R; Ruiz-Duque,B; López-Campos,JL] Unidad Médico-Quirúrgica de Enfermedades Respiratorias, Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/Universidad de Sevilla, Sevilla, Spain. [Carrasco-Hernández,L; Quintana-Gallego,E; Calero,C; López-Campos,JL] Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain.
Keywords: Cystic fibrosis transmembrane conductance regulator;COPD;CFTR modulators;Ivacaftor;Icenticaftor;Mucociliary clearance;Mucus;Inflammation;Phosphodiesterase inhibitors;Regulador de conductancia de transmembrana de fibrosis quística;Enfermedad pulmonar obstructiva crónica;Depuración mucociliar;Moco;Inflamación;Inhibidores de fosfodiesterasa
metadata.dc.subject.mesh: Medical Subject Headings::Chemicals and Drugs::Amino Acids, Peptides, and Proteins::Proteins::Carrier Proteins::Membrane Transport Proteins::Ion Channels::Chloride Channels::Cystic Fibrosis Transmembrane Conductance Regulator
Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Diagnostic Techniques and Procedures::Diagnostic Techniques, Respiratory System::Mucociliary Clearance
Medical Subject Headings::Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Molecular Mechanisms of Pharmacological Action::Antioxidants
Medical Subject Headings::Chemicals and Drugs::Amino Acids, Peptides, and Proteins::Proteins::Blood Proteins::Protein S
Medical Subject Headings::Phenomena and Processes::Chemical Phenomena::Physicochemical Phenomena::Viscosity
Medical Subject Headings::Diseases::Respiratory Tract Diseases::Lung Diseases::Lung Diseases, Obstructive::Pulmonary Disease, Chronic Obstructive
Medical Subject Headings::Anatomy::Fluids and Secretions::Bodily Secretions::Mucus
Medical Subject Headings::Diseases::Pathological Conditions, Signs and Symptoms::Pathologic Processes::Inflammation
Medical Subject Headings::Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Molecular Mechanisms of Pharmacological Action::Enzyme Inhibitors::Phosphodiesterase Inhibitors
Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Drug Therapy::Fluid Therapy
Medical Subject Headings::Organisms::Bacteria
Medical Subject Headings::Organisms::Viruses
Issue Date: 10-Oct-2021
Publisher: MDPI
Citation: Carrasco-Hernández L, Quintana-Gallego E, Calero C, Reinoso-Arija R, Ruiz-Duque B, López-Campos JL. Dysfunction in the Cystic Fibrosis Transmembrane Regulator in Chronic Obstructive Pulmonary Disease as a Potential Target for Personalised Medicine. Biomedicines. 2021 Oct 10;9(10):1437
Abstract: In recent years, numerous pathways were explored in the pathogenesis of COPD in the quest for new potential therapeutic targets for more personalised medical care. In this context, the study of the cystic fibrosis transmembrane conductance regulator (CFTR) began to gain importance, especially since the advent of the new CFTR modulators which had the potential to correct this protein's dysfunction in COPD. The CFTR is an ion transporter that regulates the hydration and viscosity of mucous secretions in the airway. Therefore, its abnormal function favours the accumulation of thicker and more viscous secretions, reduces the periciliary layer and mucociliary clearance, and produces inflammation in the airway, as a consequence of a bronchial infection by both bacteria and viruses. Identifying CFTR dysfunction in the context of COPD pathogenesis is key to fully understanding its role in the complex pathophysiology of COPD and the potential of the different therapeutic approaches proposed to overcome this dysfunction. In particular, the potential of the rehydration of mucus and the role of antioxidants and phosphodiesterase inhibitors should be discussed. Additionally, the modulatory drugs which enhance or restore decreased levels of the protein CFTR were recently described. In particular, two CFTR potentiators, ivacaftor and icenticaftor, were explored in COPD. The present review updated the pathophysiology of the complex role of CFTR in COPD and the therapeutic options which could be explored.
URI: http://hdl.handle.net/10668/4400
metadata.dc.relation.publisherversion: https://www.mdpi.com/2227-9059/9/10/1437/htm
metadata.dc.identifier.doi: 10.3390/biomedicines9101437
ISSN: 2227-9059 (Online)
Appears in Collections:01- Artículos - Hospital Virgen del Rocío
01- Artículos - IBIS. Instituto de Biomedicina de Sevilla

Files in This Item:
File Description SizeFormat 
CarrascoHernandez_DysfunctionIn.pdfRevisión1,17 MBAdobe PDFView/Open


This item is protected by original copyright



This item is licensed under a Creative Commons License Creative Commons